Description
Nobivac DHP
Active ingredients
A live attenuated freeze-dried vaccine containing canine distemper virus, canine adenovirus (CAV-2) and canine parvovirus (C154)
Indications
For the active immunization of healthy dogs against canine distemper virus, canine adenovirus type1(infectious canine hepatitis), canine parvovirus and against canine cough caused by canine adenovirus type 2. The puppy programmed can be completed from a minimum 10 weeks of age. The components of Nobivac DHP have been shown to protect against canine distemper virus, canine parvovirus and canine adenovirus for at least three years
The onset of immunity is one week after administration for canine distemper virus, canine parvovirus and canine adenovirus
Nobivac DHP can be used in pregnant bitches
Dosage
Reconstitute each single dose vial of the vaccine with one vial (1mL) of Nobivac diluent or Nobivac Lepto I and administer by subcutaneous injection
Each of the Nobivac vaccines fits into a larger overall vaccination programmed. The individual’s age, health (including maternal immunity) and local environmental conditions should be considered in the formulation of a vaccination programmed
Suggested Vaccination protocol
Vaccination commencing at 6- 8 weeks of age. Two doses
Age | Vaccine |
6-8 weeks | Nobivac DHP |
10 weeks | Nobivac DHP |
N.B. There must be at least two weeks between vaccinations and the pup should be at least 10 weeks of age when the final vaccination is administered
Vaccination commencing at 10 weeks of age or older. One dose
Age | Vaccine |
10 weeks or older | Nobivac DHP |